nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—hematologic cancer	0.00179	0.00179	CcSEcCtD
Bromhexine—Nausea—Dasatinib—hematologic cancer	0.00178	0.00178	CcSEcCtD
Bromhexine—Nausea—Bexarotene—hematologic cancer	0.00178	0.00178	CcSEcCtD
Bromhexine—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.00178	0.00178	CcSEcCtD
Bromhexine—Anaphylactic shock—Irinotecan—hematologic cancer	0.00178	0.00178	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Thiotepa—hematologic cancer	0.00178	0.00178	CcSEcCtD
Bromhexine—Nausea—Fludarabine—hematologic cancer	0.00177	0.00177	CcSEcCtD
Bromhexine—Diarrhoea—Vinblastine—hematologic cancer	0.00177	0.00177	CcSEcCtD
Bromhexine—Hypersensitivity—Lenalidomide—hematologic cancer	0.00177	0.00177	CcSEcCtD
Bromhexine—Vomiting—Nilotinib—hematologic cancer	0.00176	0.00176	CcSEcCtD
Bromhexine—Urticaria—Bortezomib—hematologic cancer	0.00175	0.00175	CcSEcCtD
Bromhexine—Vomiting—Imatinib—hematologic cancer	0.00175	0.00175	CcSEcCtD
Bromhexine—Pruritus—Melphalan—hematologic cancer	0.00175	0.00175	CcSEcCtD
Bromhexine—Rash—Nilotinib—hematologic cancer	0.00174	0.00174	CcSEcCtD
Bromhexine—Dermatitis—Nilotinib—hematologic cancer	0.00174	0.00174	CcSEcCtD
Bromhexine—Hypersensitivity—Hydroxyurea—hematologic cancer	0.00174	0.00174	CcSEcCtD
Bromhexine—Urticaria—Bleomycin—hematologic cancer	0.00174	0.00174	CcSEcCtD
Bromhexine—Rash—Imatinib—hematologic cancer	0.00174	0.00174	CcSEcCtD
Bromhexine—Dermatitis—Imatinib—hematologic cancer	0.00173	0.00173	CcSEcCtD
Bromhexine—Anaphylactic shock—Gemcitabine—hematologic cancer	0.00173	0.00173	CcSEcCtD
Bromhexine—Skin disorder—Mitoxantrone—hematologic cancer	0.00173	0.00173	CcSEcCtD
Bromhexine—Vomiting—Cladribine—hematologic cancer	0.00172	0.00172	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Thalidomide—hematologic cancer	0.00172	0.00172	CcSEcCtD
Bromhexine—Urticaria—Vinorelbine—hematologic cancer	0.00171	0.00171	CcSEcCtD
Bromhexine—Rash—Cladribine—hematologic cancer	0.0017	0.0017	CcSEcCtD
Bromhexine—Dermatitis—Cladribine—hematologic cancer	0.0017	0.0017	CcSEcCtD
Bromhexine—Pruritus—Lenalidomide—hematologic cancer	0.0017	0.0017	CcSEcCtD
Bromhexine—Diarrhoea—Melphalan—hematologic cancer	0.00169	0.00169	CcSEcCtD
Bromhexine—Skin disorder—Gemcitabine—hematologic cancer	0.00168	0.00168	CcSEcCtD
Bromhexine—Nausea—Chlorambucil—hematologic cancer	0.00168	0.00168	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—hematologic cancer	0.00167	0.00167	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Carmustine—hematologic cancer	0.00165	0.00165	CcSEcCtD
Bromhexine—Vomiting—Vinblastine—hematologic cancer	0.00165	0.00165	CcSEcCtD
Bromhexine—Nausea—Nilotinib—hematologic cancer	0.00164	0.00164	CcSEcCtD
Bromhexine—Diarrhoea—Lenalidomide—hematologic cancer	0.00164	0.00164	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Alitretinoin—hematologic cancer	0.00163	0.00163	CcSEcCtD
Bromhexine—Urticaria—Thiotepa—hematologic cancer	0.00163	0.00163	CcSEcCtD
Bromhexine—Nausea—Imatinib—hematologic cancer	0.00163	0.00163	CcSEcCtD
Bromhexine—Angioedema—Prednisolone—hematologic cancer	0.00163	0.00163	CcSEcCtD
Bromhexine—Hypersensitivity—Bortezomib—hematologic cancer	0.00163	0.00163	CcSEcCtD
Bromhexine—Diarrhoea—Hydroxyurea—hematologic cancer	0.00162	0.00162	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Ifosfamide—hematologic cancer	0.00162	0.00162	CcSEcCtD
Bromhexine—Anaphylactic shock—Cisplatin—hematologic cancer	0.00161	0.00161	CcSEcCtD
Bromhexine—Hypersensitivity—Bleomycin—hematologic cancer	0.00161	0.00161	CcSEcCtD
Bromhexine—Nausea—Cladribine—hematologic cancer	0.00161	0.00161	CcSEcCtD
Bromhexine—Hypersensitivity—Vinorelbine—hematologic cancer	0.00159	0.00159	CcSEcCtD
Bromhexine—Urticaria—Thalidomide—hematologic cancer	0.00158	0.00158	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Vincristine—hematologic cancer	0.00158	0.00158	CcSEcCtD
Bromhexine—Vomiting—Melphalan—hematologic cancer	0.00157	0.00157	CcSEcCtD
Bromhexine—Skin disorder—Cisplatin—hematologic cancer	0.00157	0.00157	CcSEcCtD
Bromhexine—Pruritus—Bortezomib—hematologic cancer	0.00156	0.00156	CcSEcCtD
Bromhexine—Rash—Melphalan—hematologic cancer	0.00156	0.00156	CcSEcCtD
Bromhexine—Dermatitis—Melphalan—hematologic cancer	0.00155	0.00155	CcSEcCtD
Bromhexine—Pruritus—Bleomycin—hematologic cancer	0.00155	0.00155	CcSEcCtD
Bromhexine—Nausea—Vinblastine—hematologic cancer	0.00154	0.00154	CcSEcCtD
Bromhexine—Abdominal pain upper—Epirubicin—hematologic cancer	0.00154	0.00154	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.00153	0.00153	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	0.00153	0.00153	CcSEcCtD
Bromhexine—Vomiting—Lenalidomide—hematologic cancer	0.00152	0.00152	CcSEcCtD
Bromhexine—Pruritus—Vinorelbine—hematologic cancer	0.00152	0.00152	CcSEcCtD
Bromhexine—Hypersensitivity—Thiotepa—hematologic cancer	0.00152	0.00152	CcSEcCtD
Bromhexine—Rash—Lenalidomide—hematologic cancer	0.00151	0.00151	CcSEcCtD
Bromhexine—Dermatitis—Lenalidomide—hematologic cancer	0.00151	0.00151	CcSEcCtD
Bromhexine—Diarrhoea—Bortezomib—hematologic cancer	0.00151	0.00151	CcSEcCtD
Bromhexine—Urticaria—Alitretinoin—hematologic cancer	0.0015	0.0015	CcSEcCtD
Bromhexine—Vomiting—Hydroxyurea—hematologic cancer	0.0015	0.0015	CcSEcCtD
Bromhexine—Angioedema—Triamcinolone—hematologic cancer	0.0015	0.0015	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.00149	0.00149	CcSEcCtD
Bromhexine—Rash—Hydroxyurea—hematologic cancer	0.00149	0.00149	CcSEcCtD
Bromhexine—Dermatitis—Hydroxyurea—hematologic cancer	0.00149	0.00149	CcSEcCtD
Bromhexine—Urticaria—Ifosfamide—hematologic cancer	0.00149	0.00149	CcSEcCtD
Bromhexine—Anaphylactic shock—Etoposide—hematologic cancer	0.00148	0.00148	CcSEcCtD
Bromhexine—Diarrhoea—Vinorelbine—hematologic cancer	0.00147	0.00147	CcSEcCtD
Bromhexine—Hypersensitivity—Thalidomide—hematologic cancer	0.00147	0.00147	CcSEcCtD
Bromhexine—Nausea—Melphalan—hematologic cancer	0.00147	0.00147	CcSEcCtD
Bromhexine—Anaphylactic shock—Prednisolone—hematologic cancer	0.00146	0.00146	CcSEcCtD
Bromhexine—Pruritus—Thiotepa—hematologic cancer	0.00146	0.00146	CcSEcCtD
Bromhexine—Skin disorder—Etoposide—hematologic cancer	0.00144	0.00144	CcSEcCtD
Bromhexine—Abdominal pain upper—Doxorubicin—hematologic cancer	0.00142	0.00142	CcSEcCtD
Bromhexine—Nausea—Lenalidomide—hematologic cancer	0.00142	0.00142	CcSEcCtD
Bromhexine—Urticaria—Mitoxantrone—hematologic cancer	0.00141	0.00141	CcSEcCtD
Bromhexine—Hypersensitivity—Carmustine—hematologic cancer	0.00141	0.00141	CcSEcCtD
Bromhexine—Pruritus—Thalidomide—hematologic cancer	0.00141	0.00141	CcSEcCtD
Bromhexine—Diarrhoea—Thiotepa—hematologic cancer	0.00141	0.00141	CcSEcCtD
Bromhexine—Nausea—Hydroxyurea—hematologic cancer	0.0014	0.0014	CcSEcCtD
Bromhexine—Vomiting—Bortezomib—hematologic cancer	0.0014	0.0014	CcSEcCtD
Bromhexine—Hypersensitivity—Alitretinoin—hematologic cancer	0.0014	0.0014	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.00139	0.00139	CcSEcCtD
Bromhexine—Vomiting—Bleomycin—hematologic cancer	0.00139	0.00139	CcSEcCtD
Bromhexine—Rash—Bortezomib—hematologic cancer	0.00139	0.00139	CcSEcCtD
Bromhexine—Dermatitis—Bortezomib—hematologic cancer	0.00139	0.00139	CcSEcCtD
Bromhexine—Rash—Bleomycin—hematologic cancer	0.00138	0.00138	CcSEcCtD
Bromhexine—Dermatitis—Bleomycin—hematologic cancer	0.00138	0.00138	CcSEcCtD
Bromhexine—Hypersensitivity—Ifosfamide—hematologic cancer	0.00138	0.00138	CcSEcCtD
Bromhexine—Vomiting—Vinorelbine—hematologic cancer	0.00137	0.00137	CcSEcCtD
Bromhexine—Angioedema—Dexamethasone—hematologic cancer	0.00136	0.00136	CcSEcCtD
Bromhexine—Angioedema—Betamethasone—hematologic cancer	0.00136	0.00136	CcSEcCtD
Bromhexine—Diarrhoea—Thalidomide—hematologic cancer	0.00136	0.00136	CcSEcCtD
Bromhexine—Rash—Vinorelbine—hematologic cancer	0.00136	0.00136	CcSEcCtD
Bromhexine—Dermatitis—Vinorelbine—hematologic cancer	0.00136	0.00136	CcSEcCtD
Bromhexine—Immune system disorder—Prednisone—hematologic cancer	0.00135	0.00135	CcSEcCtD
Bromhexine—Hypersensitivity—Vincristine—hematologic cancer	0.00134	0.00134	CcSEcCtD
Bromhexine—Anaphylactic shock—Triamcinolone—hematologic cancer	0.00134	0.00134	CcSEcCtD
Bromhexine—Pruritus—Alitretinoin—hematologic cancer	0.00134	0.00134	CcSEcCtD
Bromhexine—Pruritus—Ifosfamide—hematologic cancer	0.00132	0.00132	CcSEcCtD
Bromhexine—Nausea—Bortezomib—hematologic cancer	0.00131	0.00131	CcSEcCtD
Bromhexine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.00131	0.00131	CcSEcCtD
Bromhexine—Hypersensitivity—Irinotecan—hematologic cancer	0.00131	0.00131	CcSEcCtD
Bromhexine—Vomiting—Thiotepa—hematologic cancer	0.00131	0.00131	CcSEcCtD
Bromhexine—Diarrhoea—Carmustine—hematologic cancer	0.00131	0.00131	CcSEcCtD
Bromhexine—Nausea—Bleomycin—hematologic cancer	0.0013	0.0013	CcSEcCtD
Bromhexine—Rash—Thiotepa—hematologic cancer	0.0013	0.0013	CcSEcCtD
Bromhexine—Dermatitis—Thiotepa—hematologic cancer	0.0013	0.0013	CcSEcCtD
Bromhexine—Diarrhoea—Alitretinoin—hematologic cancer	0.0013	0.0013	CcSEcCtD
Bromhexine—Diarrhoea—Ifosfamide—hematologic cancer	0.00128	0.00128	CcSEcCtD
Bromhexine—Nausea—Vinorelbine—hematologic cancer	0.00128	0.00128	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Etoposide—hematologic cancer	0.00128	0.00128	CcSEcCtD
Bromhexine—Vomiting—Thalidomide—hematologic cancer	0.00127	0.00127	CcSEcCtD
Bromhexine—Rash—Thalidomide—hematologic cancer	0.00126	0.00126	CcSEcCtD
Bromhexine—Dermatitis—Thalidomide—hematologic cancer	0.00125	0.00125	CcSEcCtD
Bromhexine—Diarrhoea—Vincristine—hematologic cancer	0.00125	0.00125	CcSEcCtD
Bromhexine—Pruritus—Gemcitabine—hematologic cancer	0.00122	0.00122	CcSEcCtD
Bromhexine—Nausea—Thiotepa—hematologic cancer	0.00122	0.00122	CcSEcCtD
Bromhexine—Anaphylactic shock—Betamethasone—hematologic cancer	0.00122	0.00122	CcSEcCtD
Bromhexine—Anaphylactic shock—Dexamethasone—hematologic cancer	0.00122	0.00122	CcSEcCtD
Bromhexine—Diarrhoea—Irinotecan—hematologic cancer	0.00122	0.00122	CcSEcCtD
Bromhexine—Diarrhoea—Mitoxantrone—hematologic cancer	0.00122	0.00122	CcSEcCtD
Bromhexine—Vomiting—Carmustine—hematologic cancer	0.00122	0.00122	CcSEcCtD
Bromhexine—Rash—Carmustine—hematologic cancer	0.00121	0.00121	CcSEcCtD
Bromhexine—Dermatitis—Carmustine—hematologic cancer	0.0012	0.0012	CcSEcCtD
Bromhexine—Vomiting—Alitretinoin—hematologic cancer	0.0012	0.0012	CcSEcCtD
Bromhexine—Rash—Alitretinoin—hematologic cancer	0.00119	0.00119	CcSEcCtD
Bromhexine—Dermatitis—Alitretinoin—hematologic cancer	0.00119	0.00119	CcSEcCtD
Bromhexine—Vomiting—Ifosfamide—hematologic cancer	0.00119	0.00119	CcSEcCtD
Bromhexine—Hypersensitivity—Cisplatin—hematologic cancer	0.00119	0.00119	CcSEcCtD
Bromhexine—Angioedema—Prednisone—hematologic cancer	0.00119	0.00119	CcSEcCtD
Bromhexine—Diarrhoea—Gemcitabine—hematologic cancer	0.00118	0.00118	CcSEcCtD
Bromhexine—Nausea—Thalidomide—hematologic cancer	0.00118	0.00118	CcSEcCtD
Bromhexine—Rash—Ifosfamide—hematologic cancer	0.00118	0.00118	CcSEcCtD
Bromhexine—Dermatitis—Ifosfamide—hematologic cancer	0.00118	0.00118	CcSEcCtD
Bromhexine—Urticaria—Etoposide—hematologic cancer	0.00117	0.00117	CcSEcCtD
Bromhexine—Vomiting—Vincristine—hematologic cancer	0.00116	0.00116	CcSEcCtD
Bromhexine—Urticaria—Prednisolone—hematologic cancer	0.00116	0.00116	CcSEcCtD
Bromhexine—Rash—Vincristine—hematologic cancer	0.00115	0.00115	CcSEcCtD
Bromhexine—Dermatitis—Vincristine—hematologic cancer	0.00115	0.00115	CcSEcCtD
Bromhexine—Nausea—Carmustine—hematologic cancer	0.00114	0.00114	CcSEcCtD
Bromhexine—Vomiting—Mitoxantrone—hematologic cancer	0.00113	0.00113	CcSEcCtD
Bromhexine—Vomiting—Irinotecan—hematologic cancer	0.00113	0.00113	CcSEcCtD
Bromhexine—Immune system disorder—Methotrexate—hematologic cancer	0.00113	0.00113	CcSEcCtD
Bromhexine—Nausea—Alitretinoin—hematologic cancer	0.00112	0.00112	CcSEcCtD
Bromhexine—Rash—Mitoxantrone—hematologic cancer	0.00112	0.00112	CcSEcCtD
Bromhexine—Rash—Irinotecan—hematologic cancer	0.00112	0.00112	CcSEcCtD
Bromhexine—Dermatitis—Irinotecan—hematologic cancer	0.00112	0.00112	CcSEcCtD
Bromhexine—Dermatitis—Mitoxantrone—hematologic cancer	0.00112	0.00112	CcSEcCtD
Bromhexine—Nausea—Ifosfamide—hematologic cancer	0.00111	0.00111	CcSEcCtD
Bromhexine—Diarrhoea—Cisplatin—hematologic cancer	0.0011	0.0011	CcSEcCtD
Bromhexine—Vomiting—Gemcitabine—hematologic cancer	0.0011	0.0011	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.0011	0.0011	CcSEcCtD
Bromhexine—Rash—Gemcitabine—hematologic cancer	0.00109	0.00109	CcSEcCtD
Bromhexine—Dermatitis—Gemcitabine—hematologic cancer	0.00109	0.00109	CcSEcCtD
Bromhexine—Hypersensitivity—Etoposide—hematologic cancer	0.00109	0.00109	CcSEcCtD
Bromhexine—Nausea—Vincristine—hematologic cancer	0.00108	0.00108	CcSEcCtD
Bromhexine—Hypersensitivity—Prednisolone—hematologic cancer	0.00107	0.00107	CcSEcCtD
Bromhexine—Urticaria—Triamcinolone—hematologic cancer	0.00107	0.00107	CcSEcCtD
Bromhexine—Anaphylactic shock—Prednisone—hematologic cancer	0.00106	0.00106	CcSEcCtD
Bromhexine—Nausea—Irinotecan—hematologic cancer	0.00106	0.00106	CcSEcCtD
Bromhexine—Nausea—Mitoxantrone—hematologic cancer	0.00106	0.00106	CcSEcCtD
Bromhexine—Immune system disorder—Epirubicin—hematologic cancer	0.00105	0.00105	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.00105	0.00105	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.00105	0.00105	CcSEcCtD
Bromhexine—Pruritus—Etoposide—hematologic cancer	0.00105	0.00105	CcSEcCtD
Bromhexine—Skin disorder—Prednisone—hematologic cancer	0.00103	0.00103	CcSEcCtD
Bromhexine—Nausea—Gemcitabine—hematologic cancer	0.00103	0.00103	CcSEcCtD
Bromhexine—Vomiting—Cisplatin—hematologic cancer	0.00103	0.00103	CcSEcCtD
Bromhexine—Rash—Cisplatin—hematologic cancer	0.00102	0.00102	CcSEcCtD
Bromhexine—Dermatitis—Cisplatin—hematologic cancer	0.00102	0.00102	CcSEcCtD
Bromhexine—Diarrhoea—Etoposide—hematologic cancer	0.00101	0.00101	CcSEcCtD
Bromhexine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000988	0.000988	CcSEcCtD
Bromhexine—Immune system disorder—Doxorubicin—hematologic cancer	0.000975	0.000975	CcSEcCtD
Bromhexine—Urticaria—Betamethasone—hematologic cancer	0.000966	0.000966	CcSEcCtD
Bromhexine—Urticaria—Dexamethasone—hematologic cancer	0.000966	0.000966	CcSEcCtD
Bromhexine—Nausea—Cisplatin—hematologic cancer	0.000958	0.000958	CcSEcCtD
Bromhexine—Pruritus—Triamcinolone—hematologic cancer	0.000949	0.000949	CcSEcCtD
Bromhexine—Vomiting—Etoposide—hematologic cancer	0.00094	0.00094	CcSEcCtD
Bromhexine—Rash—Etoposide—hematologic cancer	0.000932	0.000932	CcSEcCtD
Bromhexine—Dermatitis—Etoposide—hematologic cancer	0.000931	0.000931	CcSEcCtD
Bromhexine—Rash—Prednisolone—hematologic cancer	0.000919	0.000919	CcSEcCtD
Bromhexine—Dermatitis—Prednisolone—hematologic cancer	0.000918	0.000918	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.000917	0.000917	CcSEcCtD
Bromhexine—Anaphylactic shock—Methotrexate—hematologic cancer	0.000885	0.000885	CcSEcCtD
Bromhexine—Nausea—Etoposide—hematologic cancer	0.000878	0.000878	CcSEcCtD
Bromhexine—Nausea—Prednisolone—hematologic cancer	0.000866	0.000866	CcSEcCtD
Bromhexine—Pruritus—Betamethasone—hematologic cancer	0.000861	0.000861	CcSEcCtD
Bromhexine—Pruritus—Dexamethasone—hematologic cancer	0.000861	0.000861	CcSEcCtD
Bromhexine—Skin disorder—Methotrexate—hematologic cancer	0.00086	0.00086	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	0.000858	0.000858	CcSEcCtD
Bromhexine—Vomiting—Triamcinolone—hematologic cancer	0.000853	0.000853	CcSEcCtD
Bromhexine—Rash—Triamcinolone—hematologic cancer	0.000845	0.000845	CcSEcCtD
Bromhexine—Dermatitis—Triamcinolone—hematologic cancer	0.000845	0.000845	CcSEcCtD
Bromhexine—Urticaria—Prednisone—hematologic cancer	0.000842	0.000842	CcSEcCtD
Bromhexine—Diarrhoea—Dexamethasone—hematologic cancer	0.000832	0.000832	CcSEcCtD
Bromhexine—Diarrhoea—Betamethasone—hematologic cancer	0.000832	0.000832	CcSEcCtD
Bromhexine—Anaphylactic shock—Epirubicin—hematologic cancer	0.000829	0.000829	CcSEcCtD
Bromhexine—Skin disorder—Epirubicin—hematologic cancer	0.000805	0.000805	CcSEcCtD
Bromhexine—Nausea—Triamcinolone—hematologic cancer	0.000796	0.000796	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	0.000794	0.000794	CcSEcCtD
Bromhexine—Hypersensitivity—Prednisone—hematologic cancer	0.000781	0.000781	CcSEcCtD
Bromhexine—Vomiting—Dexamethasone—hematologic cancer	0.000774	0.000774	CcSEcCtD
Bromhexine—Vomiting—Betamethasone—hematologic cancer	0.000774	0.000774	CcSEcCtD
Bromhexine—Rash—Dexamethasone—hematologic cancer	0.000767	0.000767	CcSEcCtD
Bromhexine—Rash—Betamethasone—hematologic cancer	0.000767	0.000767	CcSEcCtD
Bromhexine—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000767	0.000767	CcSEcCtD
Bromhexine—Dermatitis—Dexamethasone—hematologic cancer	0.000766	0.000766	CcSEcCtD
Bromhexine—Dermatitis—Betamethasone—hematologic cancer	0.000766	0.000766	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000764	0.000764	CcSEcCtD
Bromhexine—Pruritus—Prednisone—hematologic cancer	0.00075	0.00075	CcSEcCtD
Bromhexine—Skin disorder—Doxorubicin—hematologic cancer	0.000745	0.000745	CcSEcCtD
Bromhexine—Diarrhoea—Prednisone—hematologic cancer	0.000725	0.000725	CcSEcCtD
Bromhexine—Nausea—Dexamethasone—hematologic cancer	0.000723	0.000723	CcSEcCtD
Bromhexine—Nausea—Betamethasone—hematologic cancer	0.000723	0.000723	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.000715	0.000715	CcSEcCtD
Bromhexine—Urticaria—Methotrexate—hematologic cancer	0.000703	0.000703	CcSEcCtD
Bromhexine—Vomiting—Prednisone—hematologic cancer	0.000674	0.000674	CcSEcCtD
Bromhexine—Rash—Prednisone—hematologic cancer	0.000668	0.000668	CcSEcCtD
Bromhexine—Dermatitis—Prednisone—hematologic cancer	0.000667	0.000667	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	0.000662	0.000662	CcSEcCtD
Bromhexine—Urticaria—Epirubicin—hematologic cancer	0.000658	0.000658	CcSEcCtD
Bromhexine—Hypersensitivity—Methotrexate—hematologic cancer	0.000652	0.000652	CcSEcCtD
Bromhexine—Nausea—Prednisone—hematologic cancer	0.000629	0.000629	CcSEcCtD
Bromhexine—Pruritus—Methotrexate—hematologic cancer	0.000626	0.000626	CcSEcCtD
Bromhexine—Hypersensitivity—Epirubicin—hematologic cancer	0.000611	0.000611	CcSEcCtD
Bromhexine—Urticaria—Doxorubicin—hematologic cancer	0.000609	0.000609	CcSEcCtD
Bromhexine—Diarrhoea—Methotrexate—hematologic cancer	0.000606	0.000606	CcSEcCtD
Bromhexine—Pruritus—Epirubicin—hematologic cancer	0.000586	0.000586	CcSEcCtD
Bromhexine—Diarrhoea—Epirubicin—hematologic cancer	0.000567	0.000567	CcSEcCtD
Bromhexine—Hypersensitivity—Doxorubicin—hematologic cancer	0.000565	0.000565	CcSEcCtD
Bromhexine—Vomiting—Methotrexate—hematologic cancer	0.000563	0.000563	CcSEcCtD
Bromhexine—Rash—Methotrexate—hematologic cancer	0.000558	0.000558	CcSEcCtD
Bromhexine—Dermatitis—Methotrexate—hematologic cancer	0.000558	0.000558	CcSEcCtD
Bromhexine—Pruritus—Doxorubicin—hematologic cancer	0.000542	0.000542	CcSEcCtD
Bromhexine—Vomiting—Epirubicin—hematologic cancer	0.000527	0.000527	CcSEcCtD
Bromhexine—Nausea—Methotrexate—hematologic cancer	0.000526	0.000526	CcSEcCtD
Bromhexine—Diarrhoea—Doxorubicin—hematologic cancer	0.000525	0.000525	CcSEcCtD
Bromhexine—Rash—Epirubicin—hematologic cancer	0.000522	0.000522	CcSEcCtD
Bromhexine—Dermatitis—Epirubicin—hematologic cancer	0.000522	0.000522	CcSEcCtD
Bromhexine—Nausea—Epirubicin—hematologic cancer	0.000492	0.000492	CcSEcCtD
Bromhexine—Vomiting—Doxorubicin—hematologic cancer	0.000487	0.000487	CcSEcCtD
Bromhexine—Rash—Doxorubicin—hematologic cancer	0.000483	0.000483	CcSEcCtD
Bromhexine—Dermatitis—Doxorubicin—hematologic cancer	0.000483	0.000483	CcSEcCtD
Bromhexine—Nausea—Doxorubicin—hematologic cancer	0.000455	0.000455	CcSEcCtD
